Search Results

Astrocytes of the optic nerve exhibit a region-specific and temporally distinct response to elevated intraocular pressure.

• Authors : Mazumder, Arpan G.¹ (AUTHOR); Julé, Amélie M.² (AUTHOR); Sun, Daniel¹ (AUTHOR)

• Source: Molecular Neurodegeneration. 9/27/2023, Vol. 18 Issue 1, p1-22. 22p.

Record details

Brain clearance of protein aggregates: a close-up on astrocytes.

• Authors : Giusti, Veronica¹ (AUTHOR); Kaur, Gurkirat² (AUTHOR); Giusto, Elena¹ (AUTHOR)

• Source: Molecular Neurodegeneration. 1/16/2024, Vol. 19 Issue 1, p1-18. 18p.

Record details

Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases.

• Authors : Youn, Wongu¹ (AUTHOR); Yun, Mijin² (AUTHOR) ; Lee, C. Justin¹ (AUTHOR)

• Source: Molecular Neurodegeneration. 5/9/2025, Vol. 20 Issue 1, p1-4. 4p.

Record details

FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms.

• Authors : Stoklund Dittlau, Katarina^1,2 (AUTHOR); Terrie, Lisanne³ (AUTHOR); Baatsen, Pieter⁴ (AUTHOR)

• Source: Molecular Neurodegeneration. 1/18/2023, Vol. 18 Issue 1, p1-26. 26p.

Record details

BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.

• Authors : Zhou, John^1,2,3 (AUTHOR); Singh, Neeraj¹ (AUTHOR); Galske, James¹ (AUTHOR)

• Source: Molecular Neurodegeneration. 5/4/2023, Vol. 18 Issue 1, p1-20. 20p.

Record details

Mutations in PSEN1 predispose inflammation in an astrocyte model of familial Alzheimer's disease through disrupted regulated intramembrane proteolysis.

• Authors : Ziff OJ; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Parfitt GM

Subjects: Presenilin-1*/Presenilin-1*/Presenilin-1*/genetics ; Presenilin-1*/Presenilin-1*/Presenilin-1*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/genetics

• Source: Molecular neurodegeneration [Mol Neurodegener] 2025 Jun 20; Vol. 20 (1), pp. 73. Date of Electronic Publication: 2025 Jun 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326

Record details

hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer's disease and potential therapeutics.

• Authors : TCW, Julia^1,2,3 (AUTHOR) ; Arranz, Amaia M.^4,5 (AUTHOR)

• Source: Molecular Neurodegeneration. 3/25/2023, Vol. 18 Issue 1, p1-4. 4p.

Record details

Mechanisms of astrocyte aging in reactivity and disease.

• Authors : Gildea HK; Institute for Translational Neuroscience, NYU Grossman School of Medicine, New York, USA. .; Liddelow SA

Subjects: Astrocytes*/Astrocytes*/Astrocytes*/pathology ; Astrocytes*/Astrocytes*/Astrocytes*/physiology ; Astrocytes*/Astrocytes*/Astrocytes*/metabolism

• Source: Molecular neurodegeneration [Mol Neurodegener] 2025 Feb 21; Vol. 20 (1), pp. 21. Date of Electronic Publication: 2025 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326

Record details

Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice.

• Authors : Larramona-Arcas, Raquel¹ (AUTHOR); González-Arias, Candela² (AUTHOR); Perea, Gertrudis² (AUTHOR)

• Source: Molecular Neurodegeneration. 6/9/2020, Vol. 15 Issue 1, p1-23. 23p. 1 Diagram, 8 Graphs.

Record details

17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

• Authors : Kathryn R. Bowles; Derian A. Pugh; Yiyuan Liu

Subjects: 17q21.31; Parkinson’s disease; LRRC37A

• Source: Molecular Neurodegeneration, Vol 17, Iss 1, Pp 1-21 (2022)

Record details